These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 27617404)
61. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1. Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051 [TBL] [Abstract][Full Text] [Related]
62. Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1. Rutkowski JL; Wu K; Gutmann DH; Boyer PJ; Legius E Hum Mol Genet; 2000 Apr; 9(7):1059-66. PubMed ID: 10767330 [TBL] [Abstract][Full Text] [Related]
63. Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications. Gottfried ON; Viskochil DH; Fults DW; Couldwell WT Neurosurgery; 2006 Jan; 58(1):1-16; discussion 1-16. PubMed ID: 16385324 [TBL] [Abstract][Full Text] [Related]
64. NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors. Perry A; Roth KA; Banerjee R; Fuller CE; Gutmann DH Am J Pathol; 2001 Jul; 159(1):57-61. PubMed ID: 11438454 [TBL] [Abstract][Full Text] [Related]
65. Secretome survey of human plexiform neurofibroma derived Schwann Cells reveals a secreted form of the RARRES1 protein. Chen HL; Seol H; Brown KJ; Gordish-Dressman H; Hill A; Gallo V; Packer R; Hathout Y Int J Mol Sci; 2012; 13(7):9380-9399. PubMed ID: 22942771 [TBL] [Abstract][Full Text] [Related]
66. PTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumors. Keng VW; Rahrmann EP; Watson AL; Tschida BR; Moertel CL; Jessen WJ; Rizvi TA; Collins MH; Ratner N; Largaespada DA Cancer Res; 2012 Jul; 72(13):3405-13. PubMed ID: 22700876 [TBL] [Abstract][Full Text] [Related]
67. Influence of hormones and hormone metabolites on the growth of Schwann cells derived from embryonic stem cells and on tumor cell lines expressing variable levels of neurofibromin. Roth TM; Ramamurthy P; Muir D; Wallace MR; Zhu Y; Chang L; Barald KF Dev Dyn; 2008 Feb; 237(2):513-24. PubMed ID: 18213578 [TBL] [Abstract][Full Text] [Related]
68. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors. Beert E; Brems H; Daniëls B; De Wever I; Van Calenbergh F; Schoenaers J; Debiec-Rychter M; Gevaert O; De Raedt T; Van Den Bruel A; de Ravel T; Cichowski K; Kluwe L; Mautner V; Sciot R; Legius E Genes Chromosomes Cancer; 2011 Dec; 50(12):1021-32. PubMed ID: 21987445 [TBL] [Abstract][Full Text] [Related]
69. Tumorigenic properties of neurofibromin-deficient Schwann cells in culture and as syngrafts in Nf1 knockout mice. Wu M; Wallace MR; Muir D J Neurosci Res; 2005 Nov; 82(3):357-67. PubMed ID: 16180234 [TBL] [Abstract][Full Text] [Related]
70. Vascular wall cells contribute to tumourigenesis in cutaneous neurofibromas of patients with neurofibromatosis type 1. A comparative histological, ultrastructural and immunohistochemical study. Friedrich RE; Holstein AF; Middendorff R; Davidoff MS Anticancer Res; 2012 May; 32(5):2139-58. PubMed ID: 22593502 [TBL] [Abstract][Full Text] [Related]
71. Translationally controlled tumor protein is a novel biological target for neurofibromatosis type 1-associated tumors. Kobayashi D; Hirayama M; Komohara Y; Mizuguchi S; Wilson Morifuji M; Ihn H; Takeya M; Kuramochi A; Araki N J Biol Chem; 2014 Sep; 289(38):26314-26326. PubMed ID: 25092287 [TBL] [Abstract][Full Text] [Related]
73. KIR2DL5 mutation and loss underlies sporadic dermal neurofibroma pathogenesis and growth. Anastasaki C; Dahiya S; Gutmann DH Oncotarget; 2017 Jul; 8(29):47574-47585. PubMed ID: 28548933 [TBL] [Abstract][Full Text] [Related]
74. Mitotic recombination effects homozygosity for NF1 germline mutations in neurofibromas. Serra E; Rosenbaum T; Nadal M; Winner U; Ars E; Estivill X; Lázaro C Nat Genet; 2001 Jul; 28(3):294-6. PubMed ID: 11431704 [TBL] [Abstract][Full Text] [Related]
75. Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors. I. The role of tumor suppressor mutations. Carroll SL; Stonecypher MS J Neuropathol Exp Neurol; 2004 Nov; 63(11):1115-23. PubMed ID: 15581179 [TBL] [Abstract][Full Text] [Related]